Literature DB >> 12093676

Regulation of interleukin-8 by interleukin-10 and transforming growth factor beta in human monocytes infected with mycobacterium bovis.

Patricia Méndez-Samperio1, Elizabeth García, Abraham Vázquez, Janet Palma.   

Abstract

Recent studies indicate that interleukin 8 (IL-8) production contributes to the host immune responses against mycobacterial infection. In this study, we were interested to determine whether induction of IL-8 in human monocytes infected with Mycobacterium bovis was regulated by other monocyte-derived cytokines important in antimycobacterial immunity: IL-10 and transforming growth factor beta (TGF-beta). Here, we report that IL-10 reduced, in a graded and significant manner, IL-8 production by M. bovis-infected human monocytes. Additionally, the specificity of the observed inhibition was further confirmed, since the addition of an anti-IL-10 neutralizing antibody completely reversed the inhibitory effect. In contrast, addition or neutralization of TGF-beta appeared to have no significant effect on M. bovis-induced IL-8 secretion by human monocytes, whereas CD40 expression on M. bovis-infected monocytes was significantly inhibited by this cytokine. This was consistent with the finding by the reverse transcription-PCR method that pretreatment with IL-10, but not TGF-beta, potently inhibited IL-8 mRNA levels. Interestingly, neutralization of endogenous IL-10 did not significantly alter IL-8 secretion, suggesting that induction of IL-8 was not significantly affected by coexpression of IL-10 during infection of human monocytes with M. bovis. Collectively, these data indicate that IL-8 production may be regulated when human monocytes are exposed to IL-10 prior to activation with M. bovis BCG. These data will aid in our understanding of the mechanisms involved in regulating the protective immune response to stimulation with M. bovis BCG.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12093676      PMCID: PMC120036          DOI: 10.1128/cdli.9.4.802-807.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  34 in total

1.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

2.  Killing of Mycobacterium tuberculosis by neutrophils: a nonoxidative process.

Authors:  G S Jones; H J Amirault; B R Andersen
Journal:  J Infect Dis       Date:  1990-09       Impact factor: 5.226

3.  Secretion of interleukin-8 following phagocytosis of Mycobacterium tuberculosis by human monocyte cell lines.

Authors:  J S Friedland; D G Remick; R Shattock; G E Griffin
Journal:  Eur J Immunol       Date:  1992-06       Impact factor: 5.532

4.  Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation.

Authors:  I P Oswald; T A Wynn; A Sher; S L James
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

5.  IL-10 inhibits cytokine production by activated macrophages.

Authors:  D F Fiorentino; A Zlotnik; T R Mosmann; M Howard; A O'Garra
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

6.  IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor.

Authors:  P Ralph; I Nakoinz; A Sampson-Johannes; S Fong; D Lowe; H Y Min; L Lin
Journal:  J Immunol       Date:  1992-02-01       Impact factor: 5.422

7.  IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells.

Authors:  D F Fiorentino; A Zlotnik; P Vieira; T R Mosmann; M Howard; K W Moore; A O'Garra
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

8.  Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes.

Authors:  F Willems; A Marchant; J P Delville; C Gérard; A Delvaux; T Velu; M de Boer; M Goldman
Journal:  Eur J Immunol       Date:  1994-04       Impact factor: 5.532

9.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

Authors:  R de Waal Malefyt; J Haanen; H Spits; M G Roncarolo; A te Velde; C Figdor; K Johnson; R Kastelein; H Yssel; J E de Vries
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

10.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.

Authors:  R de Waal Malefyt; J Abrams; B Bennett; C G Figdor; J E de Vries
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more
  5 in total

1.  Role of type I interferon in the bacillus Calmette-Guérin-induced expression of CXCL10 from human monocytes.

Authors:  Patricia Méndez Samperio; Artemisa Trejo; Elena Miranda
Journal:  Mediators Inflamm       Date:  2004-12       Impact factor: 4.711

2.  Latent effects of fibronectin, alpha5beta1 integrin, alphaVbeta5 integrin and the cytoskeleton regulate pancreatic carcinoma cell IL-8 secretion.

Authors:  A G Lowrie; D M Salter; J A Ross
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

3.  Cytokine profiles at birth and the risk of developing severe respiratory distress and chronic lung disease.

Authors:  Majeda S Hammoud; Raj Raghupathy; Nahla Barakat; Hoda Eltomi; Deena Elsori
Journal:  J Res Med Sci       Date:  2017-05-30       Impact factor: 1.852

4.  Campylobacter fetus Induced Proinflammatory Response in Bovine Endometrial Epithelial Cells.

Authors:  Lizeth Guadalupe Campos-Múzquiz; Estela Teresita Méndez-Olvera; Monika Palacios Martínez; Daniel Martínez-Gómez
Journal:  Pol J Microbiol       Date:  2021-03-19

5.  ESAT6-induced IFNgamma and CXCL9 can differentiate severity of tuberculosis.

Authors:  Zahra Hasan; Bushra Jamil; Mussarat Ashraf; Muniba Islam; Muhammad S Yusuf; Javaid A Khan; Rabia Hussain
Journal:  PLoS One       Date:  2009-04-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.